Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.51
Delayed Data
As of Jun 23
 -0.09 / -1.18%
Today’s Change
4.00
Today|||52-Week Range
11.72
-13.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash5.5M119.3M74.1M140.6M
 
 
 
 
 
Short Term Investment Cash7.0M53.4M-45.2M64.8M
 
 
 
 
 
Cash & Short Term Investments65.9M119.3M74.1M140.6M
 
 
 
 
 
 
ReceivablesReceivables2.9M109.0K3.5M4.9M
 
 
 
 
 
 
InventoriesInventories----0.000.00--
 
Current AssetsOther Current Assets1.9M2.5M5.6M2.6M
 
 
 
 
 
Current Assets70.7M121.9M83.3M148.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross14.5M12.4M12.7M5.6M
 
 
 
 
 
Depreciation-12.1M-9.8M-10.3M-838.0K
 
 
 
 
 
Intangible Assets39.1M36.4M43.9M43.7M
 
 
 
 
 
Other Assets39.1M36.6M43.9M44.1M
 
 
 
 
 
Total Assets114.5M161.0M131.3M199.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable793.0K1.0M452.0K567.0K
 
 
 
 
 
Accrued Expenses3.6M3.8M7.2M13.8M
 
 
 
 
 
Other Current Liabilities3.7M3.9M7.4M13.8M
 
 
 
 
 
Other Liabilities6.6M6.7M9.7M16.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.000.0049.5M
 
 
Deferred Taxes-12.3M-11.3M-11.2M-13.0M
 
 
 
 
 
Other Liabilities914.0K17.2M862.0K1.2M
 
 
 
 
 
Total Liabilities35.6M36.1M40.6M94.2M
 
 
 
 
 
 
EquityMinority Interest0.000.00-7.0K-73.0K
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity79.0M124.9M90.5M104.8M
 
 
 
 
 
Total Shareholder Equity79.0M124.9M90.5M104.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding60.8M69.6M69.9M70.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.